SSRIs and POTS: Do They Help or Make It Worse?

SSRIs are often prescribed to people with POTS (Mar, 2014). You might be on sertraline (Zoloft), fluoxetine (Prozac) or escitalopram (Lexapro), sometimes from before anyone stood you up and counted your heart rate. If the medicine is helping your mood, that's a real benefit. What it does for the POTS itself is a separate question, and so is what related drugs do to your standing heart rate.

Our team sees the fast heart rate in POTS as a compensation. When you stand, gravity pulls blood away from your head, and when the systems that should hold brain blood flow steady fall behind, the heart speeds up to make up the difference. That's the lens our team uses for any medication: does it change what's driving the compensation, quiet a symptom, or push the heart even harder?

Why Are SSRIs Prescribed for POTS?

An SSRI can end up in a POTS treatment plan for 2 reasons: the symptoms were read as anxiety, or a prescriber hoped the drug would steady blood pressure and heart rate.

The anxiety label

POTS can look a lot like panic, with a pounding heart and a shaky, keyed-up feeling when you stand (Raj, 2009). In a survey of 4,835 people with POTS, 77% had met a doctor who suggested their symptoms were psychiatric or psychological before they were diagnosed, while only 28% said they actually had a psychiatric or psychological problem at that point (Shaw, 2019). When generalized anxiety is treated with medicine, guidelines name an SSRI as the first choice (NICE, 2011).

The anxiety label often doesn't hold up under testing. When Vanderbilt researchers formally assessed 21 people with POTS for psychiatric disorders, they found no more anxiety disorders or major depression than in the general population. They did find real trouble with attention that hadn't been there in childhood, and they concluded that the evidence points to biological rather than psychological causes for the anxiety clinicians see in POTS (Raj, 2009).

The blood pressure theory

Serotonin helps the midbrain regulate heart rate and blood pressure, which is why SSRIs have been tried for fainting (vasovagal syncope), with uncertain results (Sheldon, 2015). Because fainting and POTS overlap, some experts recommended sertraline for POTS too, on the idea that it might raise standing blood pressure and so ease the reflex racing of the heart (Mar, 2014).

What Does the Research Show About SSRIs in POTS?

The research is thin, and the one trial didn't go the way its authors hoped. At Vanderbilt, 39 people with POTS (37 of them women) took a single 50 mg dose of sertraline on one day and a placebo on another, in random order, then stood for 10 minutes every hour for 4 hours (Mar, 2014).

At 4 hours, standing heart rate was 102 bpm on sertraline and 106 on placebo, a difference small enough to be chance. Seated blood pressure ran a few points higher on sertraline (106 vs 101 mmHg systolic), but standing pressure didn't differ. Symptoms improved over the morning on placebo and barely moved on sertraline, and the authors wrote that the drug "may have made symptoms worse" (Mar, 2014).

Standing heart rate 4 hours after 1 dose

100110120 bpm

Sertraline 50 mgSSRI, 39 people

106102

No difference

Atomoxetine 40 mgBlocks norepinephrine reuptake, 27 people

104117

13 bpm higher

Modafinil 100 mgWakefulness drug, 54 people

101105

No difference

Placebo dayDrug day

That trial tested 1 dose over 4 hours, and people take SSRIs for months. The authors were clear that the long-term benefit is unknown and that longer studies are needed (Mar, 2014). More than a decade later, it's still the only randomized SSRI trial in POTS that our team could find. A 2020 systematic review that required a comparison group and at least a week of treatment found only 8 studies of any POTS medication, saw some favorable effect from SSRIs in individual studies, and concluded that high-quality data on POTS medications are scarce (Hasan, 2020).

Can SSRIs Cause POTS or Make It Worse?

Nothing our team has found shows an SSRI causing POTS. The clearer risk comes from drugs that block a different transporter. Your sympathetic nerves release norepinephrine to tighten blood vessels and speed the heart, then clear 80% to 90% of it by pulling it back into the nerve through the norepinephrine transporter. Block that transporter and more norepinephrine stays active, which raises sympathetic tone and can raise heart rate (Green, 2013).

POTS research learned this from a single family. In 2000, researchers described a woman with a long history of orthostatic tachycardia who carried a mutation that wiped out more than 98% of the function of 1 copy of her norepinephrine transporter gene. Standing, her norepinephrine was 923 pg/mL, about twice the healthy average of 439, and the mutation tracked with the standing heart rate rise in her relatives (Shannon, 2000).

When Vanderbilt researchers gave 27 people with POTS a single 40 mg dose of atomoxetine, an ADHD medicine that blocks this transporter, standing heart rate climbed to 121 bpm at 2 hours against 105 on placebo, and symptoms got worse (Green, 2013). The authors concluded that medicines like it "should likely be avoided" in POTS. The 2015 Heart Rhythm Society consensus is firmer: drugs that block the norepinephrine reuptake transporter "can worsen symptoms in patients with POTS and should not be administered" (Sheldon, 2015).

Some antidepressants block that transporter too. High-dose duloxetine can give healthy volunteers a POTS-like pattern of orthostatic tachycardia after repeated dosing, likely through the same mechanism (Mar, 2014). In general antidepressant trials, venlafaxine raised resting heart rate by about 4 bpm on average and by 8.5 bpm at doses above 300 mg a day, while duloxetine's average rise was about 1 bpm (FDA labels). The Canadian Cardiovascular Society lists SNRIs, tricyclic antidepressants, MAO inhibitors and ADHD stimulants among the medicines that can mimic or worsen POTS, and SSRIs aren't on that list (Raj, 2020). A 2026 review in JAMA also names stimulants and norepinephrine reuptake inhibitors among the medication effects to rule out when someone is first evaluated for POTS (Chung, 2026).

SSRIs still have side effects that can blur the picture. The drug class can cause nausea, tremor and dizziness (Mar, 2014), and nausea and lightheadedness are common POTS symptoms too (Chung, 2026).

SSRI or SNRI for POTS: What's the Difference?

The letter in the middle matters. An SSRI blocks serotonin reuptake, while an SNRI blocks serotonin and norepinephrine reuptake, and blocking norepinephrine reuptake is what raised standing heart rate in the POTS trials.

Medicine	What it blocks	What the research shows in POTS
SSRIssertraline (Zoloft), fluoxetine (Prozac), escitalopram (Lexapro)	Serotonin reuptake, with little effect on norepinephrine	A single 50 mg dose of sertraline left standing heart rate unchanged and didn't improve symptoms (Mar, 2014).
SNRIsvenlafaxine (Effexor), duloxetine (Cymbalta)	Serotonin and norepinephrine reuptake	We found no POTS trial, and they're listed among the drugs that can mimic or worsen POTS (Raj, 2020).
AtomoxetineStrattera, a non-stimulant ADHD medicine	Norepinephrine reuptake	Standing heart rate was 117 bpm vs 104 on placebo 4 hours after 1 dose, and symptoms got worse (Green, 2013).
BupropionWellbutrin	Norepinephrine and dopamine reuptake, weakly, and no serotonin	In a chart review of 47 people, standing vital signs didn't change significantly, and fewer reported fainting (Vyas, 2020).
Stimulantsmethylphenidate (Ritalin), amphetamine (Adderall)	Norepinephrine and dopamine reuptake, and they increase release	They're listed among the drugs that can mimic or worsen POTS (Raj, 2020), though 1 retrospective series reported less fatigue in hard-to-treat POTS (Kanjwal, 2012).

Mechanisms are from the FDA labels on DailyMed. Rows in red block norepinephrine reuptake.

Some clinicians do use SNRIs in POTS as second-line options when standard medicines fail or aren't tolerated (Mar, 2014). If you're on one and doing well, it's worth asking your prescriber to check your heart rate lying down and after 10 minutes standing, so any effect on the compensation shows up in numbers.

Why Can Anxiety Improve While POTS Symptoms Stay?

Our team's rule for anxiety works in both directions, because anxiety can drive the physiology and the physiology can drive anxiety. "If the anxiety comes first, we treat the anxiety. If the change in physiology comes first, then we treat the change in physiology."

SSRIs are approved for depression and anxiety disorders (FDA labels), which makes them a tool for the first case. In the second case, the racing heart is part of the compensation for falling brain blood flow, and the trial data give no sign that an SSRI changes it. A calmer mind with the same standing heart rate is what you'd expect if the physiology came first.

Telling the 2 apart takes measurement. On a tilt table test, our team watches heart rate, blood pressure, brain blood flow and CO2 together. If the heart rate climbs and brain blood flow drops without anxiety leading the way, anxiety probably isn't the main driver, and the plan targets the physiology. Our article on POTS or anxiety walks through how to tell them apart.

Do Stimulants or ADHD Medications Help POTS?

Stimulants tend to show up later in the treatment journey. A common progression our team sees starts with a beta blocker, then midodrine, then fludrocortisone to expand blood volume, and when the fatigue is still there, a stimulant. Then comes a sleep aid, because the stimulant makes it hard to sleep.

There's a reason stimulants get prescribed. Trouble with attention is real in POTS, and in that Vanderbilt study, people with POTS scored higher on inattention than healthy controls without any childhood history of it (Raj, 2009). In our team's experience, a stimulant gives a real jump in activity and clarity, and that lift comes from pushing the adrenergic system, the same system that's already working hard to hold your blood flow up, and pressing it harder can make recovery harder.

The research on stimulants in POTS is mixed. In a review of 24 people with severe POTS that hadn't responded to the usual medicines, 14 of the 18 who stayed on methylphenidate for 6 months reported marked improvement in fatigue and near-fainting, though the study had no control group and relied on what patients reported (Kanjwal, 2012). A single 100 mg dose of modafinil didn't raise standing heart rate or worsen symptoms in a placebo-controlled trial of 54 people (Kpaeyeh, 2014), while the 2015 consensus notes that modafinil can worsen tachycardia (Sheldon, 2015). The atomoxetine team expected stimulants to be poorly tolerated in POTS for the same reasons (Green, 2013).

Our team doesn't get excited about stimulants. When someone arrives on one, it usually means that once the main problem is solved, the next job is working with their prescribing doctor to taper it so the neurochemistry can settle back into balance.

Should You Stop Your SSRI Before Treatment?

No, and don't stop it on your own. Our team leaves existing medications alone at the start and works on the reflexes driving the problem first. Medications can serve as a bridge, keeping you stable while the regulation system is rebuilt. When people feel strong and want to try coming off something, that happens with their prescribing doctor, at a pace the prescriber sets.

Stopping an antidepressant can cause discontinuation symptoms of its own. In a 2025 meta-analysis of randomized trials, dizziness was the most common one, affecting about 6% of people who stopped after accounting for placebo, and the rates were lower than older reviews suggested (Kalfas, 2025). SSRI labels recommend a gradual dose reduction rather than an abrupt stop whenever possible (FDA labels). Because dizziness is also a POTS symptom, a fast stop can look like your POTS getting worse.

If you're worried about a medication, bring it to your prescribing doctor and get them on your side. Going in antagonistic, as if you know it all, tends to shut the conversation down, and then you're starting over. Something like "Here's what I'm worried about. What do you think?" gives them room to help you find the answer together.

SSRIs and POTS FAQ

Keep Reading

• POTS or anxiety? How to tell the difference
• Hyperadrenergic POTS: symptoms, causes and treatment
• What causes the high heart rate in POTS
• POTS treatment without medication
• How we evaluate and treat POTS

Dr. Keiser is a board-certified chiropractic neurologist (DC, DACNB, FABBIR), not a medical doctor (MD/DO). This content is for educational purposes and does not constitute medical advice. It is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult a qualified healthcare provider about your specific situation.

← Back to Blog